Differences in evidentiary requirements for oncology drug assessments across Health Technology assessment bodies in Germany, Spain, and France, the European Medicines Agency, and the EU Health Technology assessment Regulation
{{output}}
Background: This study compares evidentiary requirements for oncology drugs across the European Medicines Agency (EMA), the EU Health Technology Assessment Regulation (HTAR), and national Health Technology Assessment (HTA) practi... ...
